AMGN — Recent News Coverage
All news mentioning AMGN in ESEN's AI-graded feed
News stories with AMGN as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on AMGN. See /coverage/AMGN for the 30-day aggregate.
FINANCE.YAHOO.COM
·
2026-08-11
NEUTRAL
BULLISH
CORR0.58
A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?
$BCRX
$AZN
$AMGN
$SNY
$NVS
◈ ESEN AI
BioCryst has achieved profitability while its rare-disease therapeutic Orladeyo generates material cash flows, creating a compelling acquisition target in the specialty pharma space. The achievement represents meaningfu…
INSIDERMONKEY.COM
·
2026-08-10
NEUTRAL
BULLISH
CORR0.55
Jim Cramer Highlights Pharmaceutical Giants as Non-Tech Innovation Plays Like JNJ and LLY
$JNJ
$LLY
$AMGN
$BMY
◈ ESEN AI
The article reflects a thematic rotation narrative where portfolio managers seek innovation exposure outside the technology sector after an extended tech rally. Large-cap pharmaceutical companies—particularly JNJ, LLY, …
SEEKINGALPHA.COM
·
2026-08-07
NEUTRAL
BULLISH
CORR0.52
Amgen: The Market Is Underestimating Its Next Growth Phase (NASDAQ:AMGN)
$AMGN
◈ ESEN AI
Amgen appears positioned for an underappreciated growth inflection driven by two key pharmaceutical franchises—Tezspire and Repatha—both demonstrating robust commercial momentum. The elevation of 2026 revenue guidance s…
MANILATIMES.NET
·
2026-08-06
LOW
NEUTRAL
CORR0.15
CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update
$CTMX
$AMGN
$MRNA
◈ ESEN AI
CytomX Therapeutics (CTMX) released Q2 2026 financial results alongside a business update centered on its Varseta-M program, a clinical-stage therapeutic candidate. This represents routine earnings disclosure and progra…
SEEKINGALPHA.COM
·
2026-08-05
HIGH
BULLISH
CORR0.72
Amgen: First $10 Billion Quarter, More Growth Ahead (NASDAQ:AMGN)
$AMGN
◈ ESEN AI
Amgen's Q2 achievement of a $10 billion quarter represents a significant operational milestone for the biopharmaceutical sector, signaling sustained revenue growth despite structural headwinds from loss of exclusivity (…
FINANCE.YAHOO.COM
·
2026-08-05
HIGH
BULLISH
CORR0.72
Amgen gains after strong quarterly results and continued product momentum
$AMGN
◈ ESEN AI
Amgen delivered a meaningful earnings beat in Q2 2026, signaling sustained operational execution across its diversified pharmaceutical portfolio. The 4% single-day rally reflects investor confidence in management's abil…
INSURANCEJOURNAL.COM
·
2026-08-03
NEUTRAL
BEARISH
CORR-0.15
Amgen Reports Theft of Patient Data in Cyber Incident
$AMGN
◈ ESEN AI
Amgen disclosed a significant cybersecurity breach involving unauthorized access to patient data and proprietary information stored on cloud infrastructure. The incident represents a material operational and regulatory …
ECONOMICTIMES.INDIATIMES.COM
·
2026-08-02
NEUTRAL
BEARISH
CORR0.15
Drugmaker Amgen discloses data breach involving patient health information
$AMGN
◈ ESEN AI
Amgen disclosed a material data breach affecting patient health information on July 29, representing a cybersecurity incident of sufficient scope to trigger regulatory reporting obligations. The company determined mater…
FINANCE.YAHOO.COM
·
2026-08-01
NEUTRAL
NEUTRAL
CORR0.42
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?
$XLV
$PBE
$AMGN
$JNJ
◈ ESEN AI
The comparison between XLV and PBE reflects a classic trade-off in healthcare investing: concentrated volatility versus diversified stability. PBE's 41% annual surge demonstrates the upside potential of biotech-focused …
MANILATIMES.NET
·
2026-07-23
NEUTRAL
NEUTRAL
CORR0.35
Molecular Glues Clinical Trial Landscape: 80+ Emerging Competitors, Pipeline Dynamics, and Future Opportunities | DelveInsight
$AMGN
$LLY
$INCY
◈ ESEN AI
The molecular glues therapeutic landscape is experiencing significant competitive expansion, with 80+ emerging pipeline candidates competing for clinical advancement and market share. This represents a fragmented R&D en…
FINANCE.YAHOO.COM
·
2026-07-12
LOW
NEUTRAL
CORR0.42
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?
$FBT
$IBB
$AMGN
$GILD
◈ ESEN AI
This article compares FBT (First Trust Nasdaq Biotech ETF) and IBB (iShares Nasdaq Biotechnology ETF) across three structural dimensions: cost, composition, and recent performance. The analysis reveals that FBT's narrow…
SEEKINGALPHA.COM
·
2026-06-30
HIGH
BULLISH
CORR0.72
Viridian Therapeutics: Lumvoa Ready For Prime Time Following FDA Approval (NASDAQ:VRDN)
$VRDN
$AMGN
◈ ESEN AI
VRDN has secured FDA approval for Lumvoa, a therapeutic treatment in the thyroid eye disease (TED) space. This regulatory milestone represents a critical inflection point for the company, establishing market entry with …
VIDEO.FOXBUSINESS.COM
·
2026-06-28
NEUTRAL
BEARISH
CORR0.15
Nearly 1 million bottles of heart and kidney medication recalled over foreign substance found on tablets
$AMGN
◈ ESEN AI
Amgen initiated a recall of approximately one million bottles of Corlanor (ivabradine) and Sensipar (cinacalcet) following FDA notification of foreign substance contamination on tablet surfaces. Both medications address…
SEEKINGALPHA.COM
·
2026-06-26
LOW
NEUTRAL
CORR0.42
Amgen Continues To Perform (NASDAQ:AMGN)
$AMGN
◈ ESEN AI
Amgen (AMGN) continues to demonstrate operational resilience with analyst ratings clustering around Hold-to-Buy territory, suggesting market consensus views the stock as trading near intrinsic value. The valuation asses…
CNBC
·
2026-06-25
HIGH
BULLISH
CORR0.72
Obesity drugs approach a major milestone, and Lilly may have a 'game changer' ahead
$LLY
$NVO
$AMGN
◈ ESEN AI
The obesity drug sector is approaching a critical inflection point, with Eli Lilly positioning itself as a potential market leader through pipeline advancement. This development represents significant capital allocation…
ZACKS.COM
·
2026-06-19
LOW
NEUTRAL
CORR0.52
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
$AMGN
◈ ESEN AI
Amgen (AMGN) is experiencing increased user engagement on Zacks.com, signaling renewed retail and analyst interest in the biopharmaceutical heavyweight. This uptick in attention typically reflects either emerging cataly…
INSIDERMONKEY.COM
·
2026-06-11
NEUTRAL
BULLISH
CORR0.58
7 Best Longevity Stocks to Buy Now
$AMGN
$JNJ
◈ ESEN AI
The longevity investment theme reflects structural demographic shifts toward aging populations and increased healthcare spending. Companies positioned in anti-aging biotechnology, geriatric care, and chronic disease man…
EXPLORE OTHER FILTERS